Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,7011,720 of 20,252 grants

Active NON-SBIR/STTR RPGS
Interrogating MRCK Protein Kinases in Ovarian Cancer
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2029

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as “NOT-CA- 24-044. Uterine serous carcinoma (USC) is the deadli...

$2.35M
USD
Active NON-SBIR/STTR RPGS
IMAT-ITCR Collaboration: A Cytoscape Toolkit to Model Proteoform-Resolved Cancer Networks
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2027

ABSTRACT A single gene can give rise to several alternatively spliced protein isoforms (i.e., proteoforms) that acquire cancer-promoting functions. These cancer-associated proteofo...

$807.5K
USD
Completed NON-SBIR/STTR RPGS
Novel Strategy to Augmenting Immunotherapy against Melanoma
NATIONAL CANCER INSTITUTE University of Kentucky United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The overarching goal of this R21 proposal is to explore the potential of nelfinavir, a widely used antiviral agent, as a modulator to significantly augment...

$1.77M
USD
Active NON-SBIR/STTR RPGS
Novel MUC1 Theranostic Peptides for Imaging and Treatment of Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

ABSTRACT. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer defined by a poor overall prognosis, aggressive and early pattern of metastases, and a lack...

$4.63M
USD
Active NON-SBIR/STTR RPGS
Development of chemical probe targeting NSD3 SET domain in breast cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

Abstract Epigenetic abnormalities are common in human cancers and play a critical role in tumorigenesis via dysregulation of gene expression and by affecting chromatin function. Nu...

$5.72M
USD
Completed NON-SBIR/STTR RPGS
ATP-responsive Nanoparticles for Reversal of Immune Evasion in Breast Cancer
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2024 – 2026

Summary Antibody-drug conjugates (ADCs) have driven a revolution in the treatment of breast cancer; however, the long-term benefits on patients are still heterogeneous. ADCs induce...

$2.31M
USD
Completed NON-SBIR/STTR RPGS
Circulating tumor DNA guided de-escalation of frontline diffuse large B-cell lymphoma therapy
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2026

PROJECT SUMMARY The treatment paradigm for newly diagnosed diffuse large B-cell lymphoma (DLBCL) has largely remained unchanged: a uniformly applied regimen of 6 cycles of rituxima...

$822.5K
USD
Completed NON-SBIR/STTR RPGS
Deciphering the dichotomy of oxygen metabolism in renal cancer using a novel genetically encoded oxygen biosensor
NATIONAL CANCER INSTITUTE Scintillon Institute for Photobiology United States 2024 – 2026

Abstract Molecular oxygen (O2) plays a crucial role in shaping Earth's biosphere. It is generally accepted that the rise of oxygen in the atmosphere led living systems to evol...

$963K
USD
Active NON-SBIR/STTR RPGS
Manipulating Aberrant Calcium Signaling to Target Relapsed High-Risk Neuroblastoma
NATIONAL CANCER INSTITUTE Western New England University United States 2024 – 2027

Project Summary (30 lines) High-risk Neuroblastoma (HRNB) is an extracranial pediatric cancer in which up to 65% of patients are resistant to therapies. Recent biomedical advances...

$4.24M
USD
Completed OTHER RESEARCH-RELATED
LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living with Metastatic Lung Cancer
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2025

Patients are living longer with metastatic lung cancer (i.e., metavivors) due to therapeutic advances, but face significant challenges. Most metavivors will ultimately die of cance...

$1.02M
USD
Completed OTHER RESEARCH-RELATED
Integration of multi-omics to predict and evaluate response during optimization of a nutrition intervention for cancer survivors with overweight and obesity
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2026

PROJECT SUMMARY Cancer survivors with overweight or obesity (ow/ob) display increased morbidity and mortality even after amelioration of disease. Improvements in dietary and physic...

$1.17M
USD
Active NON-SBIR/STTR RPGS
Academic-Industrial Partnership for Barrett's Esophagus Detection and Risk Assessment
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Summary. This is a Type 2 R01 renewal application to continue studying Barrett’s esophagus (BE), a premalignant condition wherein the normal squamous esophageal lining is replaced...

$7.91M
USD
Active NON-SBIR/STTR RPGS
The Carolina Endometrial Cancer Study: A population-based survivor cohort
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

ABSTRACT Endometrial cancer is the 4th most common cancer diagnosed and 6th leading cause of cancer death among United States (U.S.) women. Today, there are more than 891,000 endom...

$6.59M
USD
Active NON-SBIR/STTR RPGS
Cue-101 and TCR-T cell Combinatorial Strategy for HPV+ Head and Neck Cancers
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

PROJECT SUMMARY Human papillomavirus (HPV) is the causative agent of a growing proportion of incident cases of head and neck squamous cell carcinomas (HNSCCs). HPV type 16 is respo...

$6.92M
USD
Active NON-SBIR/STTR RPGS
An integrated functional proteomics platform for accelerated discovery of isoform-specific determinants of cancer
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2027

PROJECT SUMMARY Aberrant splicing is a major mechanism leading to the progression of cancer, and newly emerging experimental and computational approaches reveal a critically import...

$4.12M
USD
Completed NON-SBIR/STTR RPGS
Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2024

Our central hypothesis is that targeting regulatory genes of cancer progression will impede tumor growth and prevent disease recurrence. Our study goals are two-fold: to discover c...

$886.9K
USD
Active TRAINING, INDIVIDUAL
Improving bacterial cancer therapeutics
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2028

PROJECT SUMMARY (ABSTRACT) Bacterial cancer therapy has existed since Dr. William Coley employed deliberate bacterial infection of tumors over a century ago in the first known exam...

$509.4K
USD
Active TRAINING, INDIVIDUAL
Reprogramming Antigen Presenting Cells in Lymph Nodes to Overcome Tumor Immune Tolerance
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2027

Abstract: Most cancer-related deaths are a consequence of metastatic disease. Yet, our understanding of the underlying mechanisms responsible for metastasis—especially the immune s...

$738.3K
USD
Active NON-SBIR/STTR RPGS
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
NATIONAL CANCER INSTITUTE Tufts Medical Center United States 2024 – 2029

Abstract Our objective is to develop tools that improve early diagnosis of systemic light-chain (AL) amyloidosis, a disease that causes heart and kidney failure and early death, in...

$8.62M
USD
Active OTHER RESEARCH-RELATED
Robust and Interpretable Multimodal Machine Learning Models for Diagnosis and Prognosis of Prostate Cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

ABSTRACT Prostate cancer is the second leading cause of cancer death and affects about 13 out of 100 American men. The standard diagnosis approach for prostate cancer incorporates...

$1.55M
USD